Nurse Practitioner, Family · Brunswick, GA
NPI
1366987844
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2500 Starling St Ste 150
Brunswick, GA, 31520
Phone (912) 466-5601
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
1,584 services
Medicare patients, 2024
184
Average age 72
Drug cost, 2024
$2.3M
4,617 prescriptions
Company payments, 2025
$2,986
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristin S Orendorf was code 99214 (office e&m - established), 490 times for 175 patients. In total Kristin S Orendorf billed 1,584 services in 9 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 490 | 175 | $69.28 | $34K |
| 82962 Clinical Chemistry | Office | 472 | 165 | $3.12 | $1,472 |
| 83036 Blood Count | Office | 346 | 152 | $9.28 | $3,209 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 165 | 129 | $10.39 | $1,714 |
| 95251 Test - Miscellaneous | Office | 87 | 63 | $21.57 | $1,876 |
| 99204 Office E&M - New | Office | 15 | 15 | $98.52 | $1,478 |
By year: 2022 $29K for 918 services; 2023 $44K for 1,476 services; 2024 $44K for 1,584 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 472 | 165 | $3.12 | $1,472 |
| 83036 Blood Count | 346 | 152 | $9.28 | $3,209 |
Medicare prescription drug claims, 2024
In 2024, the drug Kristin S Orendorf prescribed most often to Medicare patients was Ozempic (Semaglutide), with 482 prescriptions and refills. In total Kristin S Orendorf wrote 4,617 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 482 | 676 | 99 | $654K |
| Levothyroxine Sodium Generic | 337 | 919 | 102 | $3,648 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 237 | 418 | 62 | $282K |
| Mounjaro Tirzepatide | 211 | 235 | 35 | $247K |
| Metformin Hcl Er Metformin Hcl | 202 | 557 | 71 | $2,763 |
| Tresiba Flextouch U-100 Insulin Degludec | 156 | 322 | 48 | $76K |
| Atorvastatin Calcium Generic | 136 | 404 | 48 | $1,103 |
| Trulicity Dulaglutide | 123 | 168 | 28 | $162K |
| Novolog Flexpen Insulin Aspart | 119 | 215 | 40 | $27K |
| Jardiance Empagliflozin | 110 | 215 | 33 | $127K |
| Farxiga Dapagliflozin Propanediol | 106 | 212 | 24 | $116K |
| Metformin Hcl Generic | 106 | 293 | 39 | $3,351 |
| Novolog Insulin Aspart | 98 | 203 | 36 | $27K |
| Gabapentin Generic | 86 | 171 | 24 | $1,215 |
| Januvia Sitagliptin Phosphate | 81 | 156 | 20 | $86K |
Brand drugs: 2,514 claims; generic drugs: 1,565 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristin S Orendorf $2,986 ($2,986 in general payments such as food, travel and fees) from 25 companies. The largest payer was Medtronic, Inc. with $1,071.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 12 | $1,071 |
| Insulet Corporation PODD | 35 | $258 |
| Novo Nordisk Inc NVO | 14 | $204 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $161 |
| Lilly USA, LLC LLY | 8 | $158 |
| Dexcom, Inc. DXCM | 7 | $150 |
| Boston Scientific Corporation BSX | 1 | $139 |
| Corcept Therapeutics CORT | 5 | $121 |
| Averitas Pharma Inc. | 3 | $92.4 |
| Sequel Med Tech, LLC | 4 | $86.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.